Spatial deficits in a mouse model of Parkinson disease

Psychopharmacology (Berl). 2007 Nov;194(4):517-25. doi: 10.1007/s00213-007-0862-4. Epub 2007 Jul 11.

Abstract

Rationale: Accumulating evidence in humans demonstrated that visuo-spatial deficits are the most consistently reported cognitive abnormalities in Parkinson disease (PD). These deficits have been generally attributed to cortical dopamine degeneration. However, more recent evidence suggests that dopamine loss in the striatum is responsible for the visuo-spatial abnormalities in PD. Studies based on animal models of PD did not specifically address this question.

Objectives: Thus, the first goal of this study was to analyze the role of dopamine within the dorsal striatum in spatial memory. We tested bilateral 6-OHDA striatal lesioned CD1 mice in an object-place association spatial task. Furthermore, to see whether the effects were selective for spatial information, we measured how the 6-OHDA-lesioned animals responded to a non-spatial change and learned in the one-trial inhibitory avoidance task.

Results: The results demonstrated that bilateral (approximately 75%) dopamine depletion of the striatum impaired spatial change discrimination. On the contrary, no effect of the lesion was observed on non-spatial novelty detection or on passive avoidance learning.

Conclusions: These results confirm that dopamine depletion is accompanied by cognitive deficits and demonstrate that striatal dopamine dysfunction is sufficient to induce spatial information processing deficits.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Animals
  • Animals, Outbred Strains
  • Avoidance Learning / drug effects
  • Avoidance Learning / physiology
  • Behavior, Animal / drug effects*
  • Behavior, Animal / physiology*
  • Cognition Disorders / chemically induced
  • Cognition Disorders / physiopathology
  • Data Interpretation, Statistical
  • Disease Models, Animal
  • Dopamine / analysis
  • Dopamine / deficiency
  • Exploratory Behavior / drug effects
  • Exploratory Behavior / physiology
  • Habituation, Psychophysiologic / drug effects
  • Habituation, Psychophysiologic / physiology
  • Immunohistochemistry
  • Mice
  • Motor Activity / drug effects
  • Motor Activity / physiology
  • Norepinephrine / analysis
  • Nucleus Accumbens / chemistry
  • Nucleus Accumbens / drug effects
  • Nucleus Accumbens / pathology
  • Oxidopamine / administration & dosage
  • Oxidopamine / toxicity
  • Parkinson Disease, Secondary / chemically induced
  • Parkinson Disease, Secondary / physiopathology*
  • Reproducibility of Results
  • Space Perception / drug effects
  • Space Perception / physiology
  • Spatial Behavior / drug effects
  • Spatial Behavior / physiology*
  • Sympatholytics / administration & dosage
  • Sympatholytics / toxicity
  • Time Factors

Substances

  • Sympatholytics
  • Oxidopamine
  • Dopamine
  • Norepinephrine